Literature DB >> 19548069

Increased serum levels of matrix metalloproteinase-9 in acute graft-versus-host disease after allogeneic haematopoietic stem cell transplantation.

Kozo Tagami1, Toshiaki Yujiri2,3, Toru Takahashi1, Nobuaki Kizuki1, Yoshinori Tanaka1, Noriyuki Mitani1, Yukinori Nakamura1, Koichi Ariyoshi1, Toshihiko Ando1, Toshikazu Gondo4, Yukio Tanizawa1.   

Abstract

Matrix metalloproteinases (MMPs) have been implicated in a variety of normal and pathological conditions that involve matrix degradation and remodelling. We investigated the role of MMPs in acute graft-versus-host disease (aGVHD) in 29 patients who had undergone allogeneic haematopoietic stem cell transplantation. The present study showed that the serum levels of MMP-9, but not those of MMP-2, significantly correlated with the occurrence and severity of aGVHD. Moreover, immunohistochemical analysis of the cutaneous lesions of patients with aGVHD revealed an increased number of inflammatory cells positive for MMP-9. These results suggest that MMP-9 might play an important role in the pathogenesis of aGVHD.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19548069     DOI: 10.1007/s12185-009-0358-6

Source DB:  PubMed          Journal:  Int J Hematol        ISSN: 0925-5710            Impact factor:   2.490


  10 in total

Review 1.  Gelatinase B: a tuner and amplifier of immune functions.

Authors:  G Opdenakker; P E Van den Steen; J Van Damme
Journal:  Trends Immunol       Date:  2001-10       Impact factor: 16.687

Review 2.  Matrix metalloproteinases: they're not just for matrix anymore!

Authors:  L J McCawley; L M Matrisian
Journal:  Curr Opin Cell Biol       Date:  2001-10       Impact factor: 8.382

3.  A metalloproteinase inhibitor prevents lethal acute graft-versus-host disease in mice.

Authors:  K Hattori; T Hirano; C Ushiyama; H Miyajima; N Yamakawa; T Ebata; Y Wada; S Ikeda; K Yoshino; M Tateno; K Oshimi; N Kayagaki; H Yagita; K Okumura
Journal:  Blood       Date:  1997-07-15       Impact factor: 22.113

Review 4.  Acute graft-vs-host disease: pathobiology and management.

Authors:  H Goker; I C Haznedaroglu; N J Chao
Journal:  Exp Hematol       Date:  2001-03       Impact factor: 3.084

Review 5.  Matrix metalloproteinase inhibitors as therapy for inflammatory and vascular diseases.

Authors:  Jialiang Hu; Philippe E Van den Steen; Qing-Xiang A Sang; Ghislain Opdenakker
Journal:  Nat Rev Drug Discov       Date:  2007-06       Impact factor: 84.694

Review 6.  Matrix metalloproteinases as modulators of inflammation.

Authors:  Anne M Manicone; John K McGuire
Journal:  Semin Cell Dev Biol       Date:  2007-07-10       Impact factor: 7.727

Review 7.  Advances in the understanding of acute graft-versus-host disease.

Authors:  Edward S Morris; Geoffrey R Hill
Journal:  Br J Haematol       Date:  2007-04       Impact factor: 6.998

8.  Matrix metalloproteinases: biologic activity and clinical implications.

Authors:  A R Nelson; B Fingleton; M L Rothenberg; L M Matrisian
Journal:  J Clin Oncol       Date:  2000-03       Impact factor: 44.544

9.  Both perforin and Fas ligand are required for the regulation of alloreactive CD8+ T cells during acute graft-versus-host disease.

Authors:  Yoshinobu Maeda; Robert B Levy; Pavan Reddy; Chen Liu; Shawn G Clouthier; Takanori Teshima; James L M Ferrara
Journal:  Blood       Date:  2004-10-05       Impact factor: 22.113

Review 10.  1994 Consensus Conference on Acute GVHD Grading.

Authors:  D Przepiorka; D Weisdorf; P Martin; H G Klingemann; P Beatty; J Hows; E D Thomas
Journal:  Bone Marrow Transplant       Date:  1995-06       Impact factor: 5.483

  10 in total
  3 in total

1.  Inhibition of plasmin attenuates murine acute graft-versus-host disease mortality by suppressing the matrix metalloproteinase-9-dependent inflammatory cytokine storm and effector cell trafficking.

Authors:  A Sato; C Nishida; K Sato-Kusubata; M Ishihara; Y Tashiro; I Gritli; H Shimazu; S Munakata; H Yagita; K Okumura; Y Tsuda; Y Okada; A Tojo; H Nakauchi; S Takahashi; B Heissig; K Hattori
Journal:  Leukemia       Date:  2014-05-05       Impact factor: 11.528

2.  Proteomic Characterization Reveals That MMP-3 Correlates With Bronchiolitis Obliterans Syndrome Following Allogeneic Hematopoietic Cell and Lung Transplantation.

Authors:  X Liu; Z Yue; J Yu; E Daguindau; K Kushekhar; Q Zhang; Y Ogata; P R Gafken; Y Inamoto; A Gracon; D S Wilkes; J A Hansen; S J Lee; J Y Chen; S Paczesny
Journal:  Am J Transplant       Date:  2016-03-14       Impact factor: 8.086

3.  The influence of autologous bone marrow stem cell transplantation on matrix metalloproteinases in patients treated for acute ST-elevation myocardial infarction.

Authors:  Eline Bredal Furenes; Trine Baur Opstad; Svein Solheim; Ketil Lunde; Harald Arnesen; Ingebjørg Seljeflot
Journal:  Mediators Inflamm       Date:  2014-09-11       Impact factor: 4.711

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.